OrbusNeich Medical Group Holdings Limited

SEHK:6929 Stock Report

Market Cap: HK$2.7b

OrbusNeich Medical Group Holdings Future Growth

Future criteria checks 1/6

OrbusNeich Medical Group Holdings's earnings are forecast to decline at 3.1% per annum while its annual revenue is expected to grow at 11.3% per year. EPS is expected to decline by 1.9% per annum. Return on equity is forecast to be 8.1% in 3 years.

Key information

-3.1%

Earnings growth rate

-1.9%

EPS growth rate

Medical Equipment earnings growth42.9%
Revenue growth rate11.3%
Future return on equity8.1%
Analyst coverage

Low

Last updated24 Sep 2024

Recent future growth updates

Recent updates

OrbusNeich Medical Group Holdings (HKG:6929) Seems To Use Debt Rather Sparingly

Dec 04
OrbusNeich Medical Group Holdings (HKG:6929) Seems To Use Debt Rather Sparingly

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

Jul 19
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jul 03
OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

May 28
Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

May 06
Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Apr 25
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Mar 13
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

Feb 04
Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Oct 20
A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Jun 01
Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Earnings and Revenue Growth Forecasts

SEHK:6929 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202723531N/AN/A1
12/31/20262074350532
12/31/20251944234453
12/31/20241693732453
6/30/202415139819N/A
3/31/2024153421221N/A
12/31/2023154451723N/A
9/30/2023152401722N/A
6/30/2023149361822N/A
3/31/2023143271923N/A
12/31/2022137182023N/A
9/30/202213291922N/A
6/30/202212801820N/A
3/31/2022122-21820N/A
12/31/2021116-41820N/A
12/31/2020887913N/A
12/31/2019967-12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6929's earnings are forecast to decline over the next 3 years (-3.1% per year).

Earnings vs Market: 6929's earnings are forecast to decline over the next 3 years (-3.1% per year).

High Growth Earnings: 6929's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 6929's revenue (11.3% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

High Growth Revenue: 6929's revenue (11.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 6929's Return on Equity is forecast to be low in 3 years time (8.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 03:23
End of Day Share Price 2025/01/28 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OrbusNeich Medical Group Holdings Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shun Kei LawCCB International Securities Limited
Zhishun SiuCCB International Securities Limited
null nullChina International Capital Corporation Limited